Costs of acid-related disorders to a health maintenance organization

American Journal of Medicine

Volumn 103, Issue 6, 1997, Pages 520-528

  Levin, Theodore R ^a,b   Schmittdiel, Julie A ^b   Kunz, Kimberly ^c   Henning, James M ^d   Henke, Curtis J ^c   Colby, Chris J ^b   Selby, Joseph V ^b  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b DIVISION OF RESEARCH   (United States)

^c Technology Assessment Group   (United States)

^d TAP Holdings Inc   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CISAPRIDE; METOCLOPRAMIDE; MISOPROSTOL; SUCRALFATE;

ADULT; AGED; COST EFFECTIVENESS ANALYSIS; DRUG COST; DRUG EFFICACY; DYSPEPSIA; GASTROESOPHAGEAL REFLUX; HEALTH MAINTENANCE ORGANIZATION; HUMAN; MAJOR CLINICAL STUDY; PEPTIC ULCER; PHARMACY; PREVALENCE; PRIORITY JOURNAL; REVIEW;

EID: 0031461294     PISSN: 00029343     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0002-9343(97)00308-2     Document Type: Article

References (28)

1. Jönsson B. Health economics in the management of acid-related diseases - moderator's summary. Scand J Gastroenterol. 29:(Suppl 201):1994;104.
2. Sonnenberg A, Everhart JE. The prevalence of self-reported peptic ulcer in the United States. Am J Public Health. 86:1996;200-205.
3. Agréus L, Svärdsudd K, Nyrén O, Tibblin G. Irritable bowel syndrome and dyspepsia in the general population: overlap and lack of stability over time. Gastroenterology. 109:1995;671-680.
4. Isolauri J, Laippala P. Prevalence of symptoms suggestive of gastroesophageal reflux disease in an adult population. Ann Med. 27:1995;67-70.
5. Petersen H. The prevalence of gastro-esophageal reflux disease. Scand J Gastroenterol. 30:(Suppl 211):1995;5-6.
6. Grainger SL, Klass HJ, Rake MO, Williams JG. Prevalence of dyspepsia: the epidemiology of overlapping symptoms. Postgrad Med J. 70:1994;154-161.
7. Kay L, Jørgensen T. Epidemiology of upper dyspepsia in a random population: prevalence, incidence, natural history and risk factors. Scand J Gastroenterol. 29:1994;1-6.
8. Drossman DA, Zhiming LI, Andruzzi E, et al. US householder survey of functional gastrointestinal disorders: prevalence, sociodemography and health impact. Dig Dis Sci. 38:1993;1569-1580.
9. Talley NJ, Weaver AL, Zinsmeister AR, Melton LJ. Onset and disappearance of gastrointestinal symptoms and functional gastrointestinal disorders. Am J Epidemiol. 136:1992;165-177.
10. Talley NJ, Zinsmeister AR, Schleck CD, Melton LJ. Dyspepsia and dyspepsia sub-groups: a population based study. Gastroenterology. 102:1992;1259-1268.
11. Nyrén O, Adami H-O, Gustavsson S, et al. Social and economic effects of non-ulcer dyspepsia. Scand J Gastroenterol. 20:(Suppl 109):1985;41-45.
12. Nyrén O, Adami H-O, Gustavsson S, Lööf L. Excess sick-listing in gastritis/dyspepsia. J Clin Gastroenterol. 8:1986;339-345.
13. Bloom BS, Fox NA, Jacobs J. Patterns of care and expenditures by California Medicaid for peptic ulcer and other acid-related diseases. J Clin Gastroenterol. 11:1989;615-620.
14. Soll AH. Medical treatment of peptic ulcer disease: practice guidelines. JAMA. 275:1996;622-629.
15. Helicobacter pylori in peptic ulcer disease. JAMA. 272:1994;65-69.
16. Jensen GA, Morrisey MA, Gaffney S, Liston DK. The new dominance of managed care: insurance trends in the 1990s. Health Affairs. 16:1997;125-136.
17. Weiner JP, Starfield BH, Steinwachs DM, Mumford LM. Development and application of a population oriented measure of ambulatory care case-mix. Med Care. 29:1991;452-472.
18. Selby JV, Ray GT, Zhang D, Colby CJ. The excess costs of medical care for patients with diabetes mellitus in a managed care population. Diabet Care. 20:1997;1396-1402.
19. Parsonnet J. Helicobacter pylori in the stomach - a paradox unmasked. NEJM. 278:1996;278-280.
20. Bloom BS, Kroch E. Time trends in peptic ulcer disease and in gastritis and duodenitis: mortality, utilization, and disability in the United States. J Clin Gastroenterol. 17:1993;333-342.
21. Raiha I, Sourander L. GI motility disorders: diagnostic workup and use of prokinetic therapy. Geriatrics. 48:1993;57-60.
22. Kao CH, Lai TI, Wang SJ, et al. Influence of age on gastric emptying in healthy Chinese. Clin Nucl Med. 19:1994;401-404.
23. Meshkinpour H, Haghighat P, Dutton C. Clinical spectrum of aperistalsis in the elderly. Am J Gastroenterol. 89:1994;1480-1483.
24. Talley NJ. Why do functional gastrointestinal disorders come and go. Dig Dis Sci. 39:1994;673-677.
25. Segal R, Russel WL, Ben-Joseph R, Mansheim B. Cost of acid peptic disorders in a managed care organization. Clin Ther. 18:1996;319-333.
26. Lipton HL, Kreling D, Collins T, Hertz KC. Assessment of the Impact of Pharmacy Benefit Managers. Baltimore, Md: Health Care Financing Administration; 1996 (PB97-103683).
27. Vakil N, Fennerty B. Cost-effectiveness of treatment regimens for H pylori infection based on a community practice effectiveness study. Gastroenterology. 1997;112:A47. Abstract.
28. Taylor JL, Zagari M, Murphy K, Freston JW. Pharmacoeconomic comparison of treatments for the eradication of Helicobacter pylori. Arch Intern Med. 157:1997;87-97.